Pain is a common but often undertreated symptom in patients with chronic kidney disease
(CKD) with a much higher prevalence than in the general population. The aim of this …

Background Sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce progression of
chronic kidney disease and the risk of cardiovascular morbidity and mortality in a wide range …

Aims Chronic kidney disease (CKD) is a growing fatal health problem worldwide associated
with vascular calcification. Therapeutic approaches are limited with higher costs and poor …

This study aimed to determine the effect of uncertainty in illness and fatigue on the health-
related quality of life of patients on dialysis. A community-based cross-sectional study was …

Rationale & Objective Female reproductive health is recognized as a predictor of morbidity,
mortality, and quality of life, although data in the setting of chronic kidney disease (CKD) are …

Chronic kidney disease (CKD) is a global health problem. CKD causes patients to be
hospitalized for a longer time to treat the disease. The impact of the hospitalization brings …

Background Patients on haemodialysis (HD) generally experience poor health-related
quality of life (HRQoL) and a broad range of physical and mental symptoms, but it is …

Aims and objectives To compare symptoms and health‐related quality of life and to examine
the relationship between these as kidney function deteriorates. Background Chronic kidney …

Background Later stage chronic kidney disease (CKD) is associated with poorer self-
perceived health-related quality of life (HRQOL), a major consideration for many patients …

Background. Transplant therapy is considered the best and often the only available
treatment for thousands of patients with organ failure that results from communicable and …